BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
156 hedge funds and large institutions have $181M invested in BioDelivery Sciences International, Inc. in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 52 reducing their positions, and 22 closing their positions.
406% more call options, than puts
Call options by funds: $5.93M | Put options by funds: $1.17M
27% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 22
3% more funds holding
Funds holding: 151 → 156 (+5)
15% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 52
18% less capital invested
Capital invested by funds: $221M → $181M (-$40.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.88M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$5.63M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$5.35M |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$30.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$10.6M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.96M |
| 4 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$1.5M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.22M |
BDSI Hedge Fund Activity: Q4 2021 in Review
156 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2021, worth a combined $181M — down 18% from $221M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new BDSI positions and 22 closed out — a net gain of 6 holders — while 44 added to existing stakes and 52 trimmed.
The largest buyer was Rubric Capital Management (New York), opening a new position worth an estimated $5.88M. The largest seller was Deerfield Management, cutting an estimated $30.8M.
- 156 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2021, up from 151 in Q3 2021.
- Funds reported $181M of BioDelivery Sciences International, Inc. stock for Q4 2021, down 18% quarter-over-quarter.
- 28 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2021 and 22 closed out, a net change of +6 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q4 2021 was Rubric Capital Management (New York), an estimated $5.88M added.
- The largest BioDelivery Sciences International, Inc. seller in Q4 2021 was Deerfield Management, an estimated $30.8M sold.
Based on aggregated 13F filings for Q4 2021.